Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Smoldering Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05565638
What this trial is testing

PROFAST Intervention in Precursor Multiple Myeloma

Who this might be right for
Cancer PreventionWeight LossSmoldering Waldenstrom Macroglobulinemia(WM)+3 more
Dana-Farber Cancer Institute 23
Not applicableLooking for participantsNCT06644625
What this trial is testing

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

Who this might be right for
Multiple MyelomaMultiple Myeloma ProgressionMonoclonal Gammopathy of Undetermined Significance (MGUS)+2 more
Wake Forest University Health Sciences 1,665
Not applicableLooking for participantsNCT05136807
What this trial is testing

Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center 400
Testing effectiveness (Phase 2)Ended earlyNCT01965834
What this trial is testing

Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Miami 6
Testing effectiveness (Phase 2)Study completedNCT01237054
What this trial is testing

Imaging in MGUS, SMM and MM

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT00099047
What this trial is testing

Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaSmoldering Multiple Myeloma
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Study completedNCT01302886
What this trial is testing

Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Novartis Pharmaceuticals 41
Testing effectiveness (Phase 2)Looking for participantsNCT05597345
What this trial is testing

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
University of Rochester 15
Testing effectiveness (Phase 2)Enrolling By InvitationNCT03815279
What this trial is testing

A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM)

Who this might be right for
Multiple MyelomaSmoldering Multiple Myeloma
Landspitali University Hospital 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT02960555
What this trial is testing

Isatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR)

Who this might be right for
Smoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT05955508
What this trial is testing

A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma (SMM)
Regeneron Pharmaceuticals 40
Testing effectiveness (Phase 2)WithdrawnNCT01660997
What this trial is testing

MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI)
Very early researchWithdrawnNCT03591614
What this trial is testing

Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma

Who this might be right for
Monoclonal GammopathySmoldering MyelomaMyeloma
Case Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT02697383
What this trial is testing

Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study

Who this might be right for
Multiple MyelomaHigh Risk Smoldering Multiple Myeloma
Memorial Sloan Kettering Cancer Center 14
Testing effectiveness (Phase 2)Looking for participantsNCT06574126
What this trial is testing

Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma

Who this might be right for
High Risk Smoldering Multiple Myeloma
PETHEMA Foundation 20
Not applicableLooking for participantsNCT05312255
What this trial is testing

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma+1 more
Roswell Park Cancer Institute 175
Testing effectiveness (Phase 2)Active Not RecruitingNCT03289299
What this trial is testing

Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant

Who this might be right for
Smoldering Multiple Myeloma
International Myeloma Foundation 87
Testing effectiveness (Phase 2)Ended earlyNCT05288062
What this trial is testing

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma+1 more
Mayo Clinic 17
Not applicableNot Yet RecruitingNCT07305662
What this trial is testing

Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot Study

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Myeloma
Seoul National University Bundang Hospital 20
Large-scale testing (Phase 3)Active Not RecruitingNCT00114101
What this trial is testing

Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Who this might be right for
DS Stage I Multiple MyelomaDS Stage II Multiple MyelomaDS Stage III Multiple Myeloma+2 more
National Cancer Institute (NCI) 460
Next Page